Sergio Traversa - Net Worth and Insider Trading
Sergio Traversa Net Worth
The estimated net worth of Sergio Traversa is at least $527,950 dollars as of 2025-07-23. Sergio Traversa is the CEO of Relmada Therapeutics Inc and owns about 734,024 shares of Relmada Therapeutics Inc (RLMD) stock worth over $527,763. Sergio Traversa is also the Director of Actinium Pharmaceuticals Inc and owns about 100 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $187. Details can be seen in Sergio Traversa's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sergio Traversa has not made any transactions after 2025-05-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sergio Traversa
Sergio Traversa Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sergio Traversa owns 2 companies in total, including Relmada Therapeutics Inc (RLMD) , and Actinium Pharmaceuticals Inc (ATNM) .
Click here to see the complete history of Sergio Traversa’s form 4 insider trades.
Insider Ownership Summary of Sergio Traversa
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2025-05-20 | director & Chief Executive Officer |
| ATNM | Actinium Pharmaceuticals Inc | 2016-04-15 | director |
Sergio Traversa Latest Holdings Summary
Sergio Traversa currently owns a total of 2 stocks. Among these stocks, Sergio Traversa owns 734,024 shares of Relmada Therapeutics Inc (RLMD) as of May 20, 2025, with a value of $527,763 and a weighting of 99.96%. Sergio Traversa also owns 100 shares of Actinium Pharmaceuticals Inc (ATNM) as of April 15, 2016, with a value of $187 and a weighting of 0.04%.
Latest Holdings of Sergio Traversa
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2025-05-20 | 734,024 | 0.72 | 527,763 |
| ATNM | Actinium Pharmaceuticals Inc | 2016-04-15 | 100 | 1.87 | 187 |
Holding Weightings of Sergio Traversa
Sergio Traversa Form 4 Trading Tracker
According to the SEC Form 4 filings, Sergio Traversa has made a total of 11 transactions in Relmada Therapeutics Inc (RLMD) over the past 5 years, including 4 buys and 7 sells. The most-recent trade in Relmada Therapeutics Inc is the acquisition of 350,000 shares on May 20, 2025, which cost Sergio Traversa around $175,000.
According to the SEC Form 4 filings, Sergio Traversa has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 100 shares on April 15, 2016, which cost Sergio Traversa around $6,060.
Insider Trading History of Sergio Traversa
- 1
Sergio Traversa Trading Performance
GuruFocus tracks the stock performance after each of Sergio Traversa's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sergio Traversa is -27.4%. GuruFocus also compares Sergio Traversa's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sergio Traversa within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sergio Traversa's insider trading performs compared to the benchmark.
Performance of Sergio Traversa
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.33 | | | | | |
| Relative Return to S&P 500(%) | 10.07 | | | | | |
Sergio Traversa Ownership Network
Ownership Network List of Sergio Traversa
Ownership Network Relation of Sergio Traversa
Sergio Traversa Owned Company Details
What does Relmada Therapeutics Inc do?
Who are the key executives at Relmada Therapeutics Inc?
Sergio Traversa is the director & Chief Executive Officer of Relmada Therapeutics Inc. Other key executives at Relmada Therapeutics Inc include Chief Financial Officer Chuck Ence , Chief Medical Officer Cedric O'gorman , and EVP & Head of R&D Thomas Wessel .
Relmada Therapeutics Inc (RLMD) Insider Trades Summary
Over the past 18 months, Sergio Traversa made 3 insider transaction in Relmada Therapeutics Inc (RLMD) with a net purchase of 590,000. Other recent insider transactions involving Relmada Therapeutics Inc (RLMD) include a net purchase of 286,107 shares made by Maged Shenouda , a net purchase of 267,931 shares made by Chuck Ence , and a net purchase of 225,000 shares made by Paul Edward Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Relmada Therapeutics Inc (RLMD) in total and bought 978,961 shares, with a net purchase of 978,961 shares. During the past 18 months, 0 shares of Relmada Therapeutics Inc (RLMD) were sold and 1,382,038 shares were bought by its insiders, resulting in a net purchase of 1,382,038 shares.
Relmada Therapeutics Inc (RLMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relmada Therapeutics Inc Insider Transactions
Sergio Traversa Mailing Address
Above is the net worth, insider trading, and ownership report for Sergio Traversa. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Sergio Traversa's mailing address is: Blue Bell Pa 19422.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
